Systagenix launches new innovative website

NewsGuard 100/100 Score

Following the highly successful global launch of the new Corporate Identity, Systagenix has today unveiled its new innovative website - www.systagenix.com.

The site has been carefully designed to feel intuitive and easy to browse, and will be a welcome resource for wound care practitioners around the world, when either searching for clinical evidence, best practice, product specifications or information relating to new innovations around wound care, including the revolutionary developments in the area of point of care testing.

Visitors to the site will have access to a wealth of clinical and scientific evidence supporting Systagenix' product portfolio, demonstrating the business commitment to developing wound care solutions for the benefit of clinicians, point of care practitioners and patients that help wounds heal, fast.

The site revolves around Systagenix unique Let's Heal™ system, which comprises of four main categories:

  • 'Let's Test™': to finally give wound care tools to aid a correct and timely diagnosis of wounds
  • 'Let's Protect™': to protect from infection, with unique products, including SILVERCEL® NON-ADHERENT...the antimicrobial designed not to stick to wounds...
  • 'Let's Promote™': to promote wound healing in ways that standard dressing can't do
  • 'Let's Comfort™', to provide a comfortable and effective healing environment for all types of wounds

SOURCE Systagenix

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
U-M study reveals potential pathway to reverse lung fibrosis